ESE and ESPE are joining forces to share their combined expertise at the 3rd Annual Forum on Endocrine Disruptors

The continuous collaboration between Europe’s leading endocrine societies – the European Society of Endocrinology (ESE) and the European Society for Paediatric Endocrinology (ESPE) has reached  the EU level, where on September 21, 15:10PM CET, the Societies will join forces in a joint   session during the Annual Forum on Endocrine Disruptors (21-22 September) which will take place in person as well as virtually , and is organised by the European Commission DG Environment During this session - “Endocrine disruptors impact: from pre-natal development to adulthood” - four leading experts in the area of endocrine disruptors will share the latest scientific insights with an audience consisting of EU decision-makers, NGOs, Industry and other key stakeholders with an interest in this area. The session will focus on endocrine disruptors in relation to minipuberty, the current high prevalence of obesity and the thyroid hormone axis and will concluded with a panel discussion and Q&A with the audience.

Previous editions of the Forum have been well attended, in 2020 approximately 700 participants joined due to the digital format of the event. This year the event will be hybrid whereby participants are able to join on-site in Brussels well as virtually.

For more details about the ESE/ESPE session click here.

For more information about the Forum and to register click here.

To read more about ESE’s Advocacy activities click here.